support for continuing enzalutamide after mcrpc progression | axel merseburger
Published 2 years ago • 263 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
3:04
researcher comment: apalutamide addition improves metastatic cspc survival | axel merseburger
-
4:39
clinical insights into prostate cancer trial data | axel merseburger
-
3:24
expert highlights from asco gu 2020 | axel merseburger
-
1:44
introducing axel merseburger
-
26:00
treating side effects of hormone therapy | #markscholzmd #alexscholz #pcri
-
41:35
【2018 高雄全民泌尿抗癌日】專9 林嘉祥-荷爾蒙治療 (adt)失效後的前列腺癌 (crpc)治療策略 —新型荷爾蒙、鐳 223、二線化療及新藥臨床試驗
-
10:22
liver and lung mets | advanced #prostatecancer | markscholzmd | alexscholz #pcri
-
30:59
the complete guide to sbrt for prostate cancer | amar kishan, md, ucla
-
1:04
how to find a bladder cancer support group | cxbladder
-
13:24
enzalutamide approved for prostate cancer with biochemical recurrence: stephen freedland, md
-
3:41
olaparib plus abiraterone could be a new first-line treatment option for mcrpc | fred saad
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
51:30
global perspectives on parp inhibitor combinations in mcrpc match play: european vs. us integrati...
-
13:52
metastatic #prostatecancer treatment case study | #markscholzmd #alexscholz #pcri
-
14:27
treatment protocol for incidental prostate cancer after holep
-
2:01
medical insight: sbrt for prostate cancer - essentia health
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
5:42
treatments for post-docetaxel prostate cancer, part ii
-
3:15
your health matters: advances in prostate cancer treatment
-
4:24
emuc18: stampede trial